Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI matches radiologists in breast cancer screening study

NCT ID NCT07298252

Diagnosis Sponsor: Carebot s.r.o. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested an AI system called Carebot AI MMG to see if it can detect breast cancer from mammograms as accurately as human radiologists. Researchers looked at 222 past mammograms from four screening centers. The AI classified each exam as low, medium, or high risk, and its results were compared to readings from three experienced radiologists. The goal was to see if the AI could match or beat human performance in spotting cancer.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

222 people

The number who actually took part.

Started

Jan 2025

Finished

Nov 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Women undergoing routine screening mammography at four participating centers in Central Europe. The analytical dataset consists of a retrospectively assembled case-control subset of 222 anonymized 2D FFDM examinations (48 malignant and 174 non-malignant) selected from a source cohort of 4,729 screening studies.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female sex * Age ≥ 18 years at the time of the screening mammogram * Screening full-field digital mammography (FFDM) examination with all four standard views (LCC, RCC, LMLO, RMLO) available * Sufficient image quality and complete DICOM metadata to allow retrospective analysis Exclusion Criteria: * Male sex * Age \< 18 years * Digital breast tomosynthesis (DBT/3D) examinations without a corresponding full 2D FFDM four-view series * Incomplete mammography series (missing one or more of LCC, RCC, LMLO, RMLO) * Corrupted or unreadable DICOM files * Missing or inconsistent key metadata (e.g., laterality, view, acquisition date)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm female breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer detection Breast cancer female Breast cancer screening Breast neoplasms

Contacts and locations

Locations

  • Dolnooravská nemocnica s poliklinikou MUDr. L. N. Jégého

    Dolný Kubín, 026 14, Slovakia

  • Nemocnica s poliklinikou Považská Bystrica

    Považská Bystrica, 017 01, Slovakia

  • Poliklinika MEDICON Budějovická

    Prague, 14000, Czechia

  • Ľubovnianska nemocnica

    Stará Ľubovňa, 064 01, Slovakia

More trials for these conditions

Other studies related to the condition(s) this trial covers.